Most clinicians cut sulfonylurea dose by 50% at the time semaglutide is started
"So Im figuring out this new one, and it is life-changing, but it also doesnt negate the fact that it cant be in the place of having a healthy relationship with food, and it cant be in the place of having a healthy relationship with exercise." What is diverticulitis and can it be caused by using GLP-1 drugs
This muscle loss is not just a cosmetic concern, it can impact your metabolism, strength, posture, and long-term health
Namely, we still arent even sure of the long-term effects of GLP-1s on the body
A dose of 40 mg once daily may be used for more severe symptoms or confirmed oesophagitis, as per clinical judgement Review at 612 weeks: Your team will assess symptom control and decide whether to continue, reduce, or stop the medication Beyond 12 weeks: Continued use only if clinically indicated for example, persistent GORD, endoscopic evidence of oesophagitis, or ongoing symptoms In line with NICE Key Therapeutic Topic KTT13 on proton pump inhibitors, the guiding principle is to use the lowest effective dose for the shortest clinically appropriate duration , with regular review and a step-down or tapering plan where possible
8 Research gaps and future directions Current research on how GLP-1RAs affect eating experience is still quite fragmented, and the findings are not always easy to compare
